Boon and bane: dodging participant burden in decentralised clinical trials
As DCT adoption increases, sponsors and CROs must mind the risk of adding patient burden while designing decentralised trials.
Redx Pharma previews development plans for idiopathic pulmonary fibrosis and fibrostenotic Crohn’s disease
Almirall to take part in FACILITATE project to enable trial data usage
US FDA lifts partial clinical suspension on Diamyd’s diabetes therapy trial
Australian researchers commence Phase I strep A vaccine trial
Lyvgen and BMS partner for Phase II lung cancer antibody trial
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreLeading clinical trials companies in the artificial intelligence theme
The future of the pharma industry will be shaped by a range of disruptive themes, with artificial intelligence (AI) being…
More themes
Insights
View MoreWho’s innovating where? Patent activity related to 3D printing decreased by 3% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced 0.3% decline in the number of 3D printing-related patent applications in Q3 2022 compared with…
Robotics innovation: Leading companies in microneedles for transdermal drug delivery
Internet of Things innovation: Leading companies in microneedles for transdermal drug delivery
Artificial Intelligence innovation: Leading companies in DNA polymorphism detection for the pharmaceutical industry
Science 37 partners with BEKHealth to access patient data